Clinical Trials Sponsored by KeifeRx, LLC

Total 10759 results

MedImmune LLC

Completed

A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations

Chronic Obstructive Pulmonary Disease

Ireland
MedImmune LLC

Withdrawn

A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants

Wheezing
MedImmune LLC

Completed

A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

Lupus

Brazil, United States, Chile, Argentina
VIVUS LLC

Completed

Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and Placebo

Erectile Dysfunction

United States
ivWatch, LLC

Completed

Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation

Extravasation of Diagnostic and Therapeutic Materials | Extravasation | Infiltration | IV Infiltration | IV Extravasation

United States
MedImmune LLC

Completed

A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease

Congenital Heart Disease

United States, Spain, United Kingdom, Canada, Belgium, Germany, Israel, Austria, Poland, Russian Federation, Sweden, Lebanon, France, Czech Republic, Hungary, Denmark, Bulgaria
Lundbeck LLC

Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States, Belarus, India, Australia, Lithuania
Lundbeck LLC

Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States
Otologics LLC

Unknown

Middle-Ear Implant With MET V Transducer (Aka MET V System)

Mixed Conductive and Sensorineural Hearing Loss, Bilateral
MedImmune LLC

Terminated

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Healthy

United States
MedImmune LLC

Terminated

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Lymphoma

United States, Poland
Pharmacyclics LLC.

Completed

Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients

Neoplasms by Site | Multiple Myeloma | Hodgkin Disease | Leukemia, Lymphocytic, Chronic | Lymphoma, Non-hodgkin

United States
VIVUS LLC

Completed

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Erectile Dysfunction

United States
MedImmune LLC

Completed

A Clinical Study to Assess the Safety of a New Influenza Vaccine

Healthy

United States
MedImmune LLC

Completed

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine (MI-MA205)

Healthy

United States
Ischemix, LLC

Completed

Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy (SUPPORT-1)

Percutaneous Coronary Intervention | Stable Coronary Artery Disease

United States, India
Lundbeck LLC

Completed

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Psychotic Disorders | Parkinson's Disease

United States, India, Italy
VIVUS LLC

Terminated

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

Hypoactive Sexual Desire Disorder

United States
VIVUS LLC

Completed

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

Obesity

United States
VIVUS LLC

Completed

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

Erectile Dysfunction
VIVUS LLC

Completed

To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.

Renal
MedImmune LLC

Completed

A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine (MI-MA182)

Influenza

United States
Pharmacyclics LLC.

Completed

Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients

Neoplasms | Hematologic Neoplasms

United States
Lundbeck LLC

Completed

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

Epilepsy
MedImmune LLC

Withdrawn

A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer

Breast Cancer

United States
VIVUS LLC

Completed

A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers (TQT)

Torsades de Pointes

United States
VIVUS LLC

Completed

A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.

Obesity

United States
HairDx, LLC

Completed

Association of Polymorphisms in the Androgen Receptor Gene and Finasteride Response in Women With Androgenetic Alopecia

Androgenetic Alopecia
VIVUS LLC

Completed

To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil

Erectile Dysfunction

United States
VIVUS LLC

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Renal Impairment

United States
MedImmune LLC

Completed

Respiratory Events Among Premature Infants

Respiratory Syncytial Virus

United States
MedImmune LLC

Completed

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

Psoriasis

United States, Canada
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas

Glioma | Glioblastoma | Astrocytoma | Brain Neoplasm | Oligodendroglioma

United States
VIVUS LLC

Completed

Topical Alprostadil for Female Sexual Arousal Disorder

Sexual Dysfunction, Physiological

United States
MedImmune LLC

Completed

Phase I Trial of Weekly MEDI-522 in Patients With Refractory Solid Tumors

Cancer

France
MedImmune LLC

Completed

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Leukemia

United States, Israel
MedImmune LLC

Completed

Study of MEDI 507 in the Treatment of Pediatric Patients (Pediatric GvHD)

Graft Versus Host Disease

United States
MedImmune LLC

Completed

A Sequential Dose-Escalation Study in Subjects With Mild Asthma

Asthma

United States
MedImmune LLC

Completed

Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program

Influenza

United States
MedImmune LLC

Withdrawn

A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma

Lymphoma, B-Cell | Lymphoma, Non-Hodgkin
ParaPRO LLC

Completed

NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

Head Lice

United States
MedImmune LLC

Completed

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Cancer

United States
ParaPRO LLC

Completed

Phototoxicity Potential of NatrOVA Creme Rinse - 1%

Head Lice

United States
MedImmune LLC

Completed

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Prostate Cancer

United States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
MedImmune LLC

Completed

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

Plaque Psoriasis

United States, Canada
MedImmune LLC

Completed

Study To Evaluate the Safety of Bivalent Vaccine

Healthy

United States
Pharmacyclics LLC.

Completed

Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors

Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
Pharmacyclics LLC.

Completed

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Carcinoma, Non-Small-Cell Lung | Brain Neoplasms | Metastases, Neoplasm

United States, France, Belgium, Germany, Canada, Netherlands, Austria, Australia
Advenchen Pharmaceuticals, LLC.

Recruiting

Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC

Small Cell Lung Cancer

United States
Janssen Research & Development, LLC
Pharmacyclics LLC.

Active, not recruiting

A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (GLOW)

Leukemia, Lymphocytic, Chronic, B-Cell

Canada, Belgium, Netherlands, Spain, Israel, United States, Czechia, Denmark, United Kingdom, France, Russian Federation, Turkey, Poland, Sweden

3

Subscribe